For: | Yu Q, Wang WX. Camrelizumab (SHR-1210) leading to reactive capillary hemangioma in the gingiva: A case report. World J Clin Cases 2020; 8(3): 624-629 [PMID: 32110675 DOI: 10.12998/wjcc.v8.i3.624] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v8/i3/624.htm |
Number | Citing Articles |
1 |
Chunxiu Wang, Kaijian Lei, Yuming Jia, Zuxin Jiang, Shanbing Wang. Complete remission of reactive cutaneous capillary endothelial proliferation caused by the programmed cell death-1 inhibitor camrelizumab achieved through thalidomide monotherapy: A case report. Experimental and Therapeutic Medicine 2023; 26(1) doi: 10.3892/etm.2023.12023
|
2 |
Xuecong Zhou, Xiaoming Yan, Yuan Wu. Reactive cutaneous capillary endothelial proliferations of the eyelids induced by camrelizumab: A case report. Biomedical Reports 2024; 20(3) doi: 10.3892/br.2024.1743
|
3 |
Yong Liu, Hui Liu, Queqiao Bian, Yanmin Guan. A 67-Year-Old Man with Grade 3 Reactive Cutaneous Capillary Endothelial Proliferation Induced by Camrelizumab First Manifested in the Oral Mucosa – A Case Report. International Journal of Surgical Pathology 2024; 32(4): 803 doi: 10.1177/10668969231195032
|
4 |
Mingjie Ge, Mengli Li, Liheng Shen. Non-surgical treatment of idiopathic gingival enlargement: A case report. Medicine 2024; 103(19): e37448 doi: 10.1097/MD.0000000000037448
|
5 |
|
6 |
George Laskaris. Periodontal Manifestations of Local and Systemic Diseases. 2023; : 251 doi: 10.1007/978-3-031-10828-0_41
|
7 |
Zhongguang Chen, Xiuhua Lu, Kelly Koral. The clinical application of camrelizumab on advanced hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2020; 14(11): 1017 doi: 10.1080/17474124.2020.1807939
|
8 |
Yi Liu, Tiancheng Chen, Chao Zhang, Weihua Pan. Emerging Treatments for Reactive Cutaneous Capillary Endothelial Proliferation. Indian Journal of Dermatology 2023; 68(1): 85 doi: 10.4103/ijd.ijd_505_22
|
9 |
Pang Hui-Mei, Huang Guang-Ming, Qin Xiao-Ling, Zhang Hong-Liang, Wei Si-Jun. Reactive Cutaneous Capillary Endothelial Proliferation Caused by Camrelizumab. Indian Journal of Dermatology 2023; 68(3): 318 doi: 10.4103/ijd.ijd_343_22
|